Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02085421 · ClinicalTrials.gov registry record · NA
Transcranial Direct Current Stimulation and Cognitive Remediation Therapy for Psychosis
A NA study, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT02085421 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 33 participants.
The verdict
NCT02085421, a NA study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
The proposed pilot study is a randomized controlled study to assess effectiveness of transcranial direct current stimulation (tDCS) to enhance cognitive remediation therapy in patients with psychotic disorders. tDCS. Patients will be randomized into two arms: active tDCS vs. sham tDCS. The active tDCS will be applied at a current of 1-2 mA (milliamperes) via two saline soaked electrode sponges (3 cm x 4.5 cm) applied to the side of the head. The investigators hypothesis is that the use of tDCS will enhance the improvement seen with cognitive remediation therapy.
Interventions
- DEVICE tDCS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2019-03-14 |
| Est. Completion | 2023-02-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02085421
The ClinicalTrials.gov registry entry for NCT02085421 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which tDCS is the first listed.
NCT02085421 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02085421 about?
NCT02085421 is a clinical study titled "Transcranial Direct Current Stimulation and Cognitive Remediation Therapy for Psychosis". The proposed pilot study is a randomized controlled study to assess effectiveness of transcranial direct current stimulation (tDCS) to enhance cognitive remediation therapy in patients with psychotic disorders. tDCS. Patients will be randomized into two arms: active tDCS vs. sham tDCS. The active tD...
What is the current status of trial NCT02085421?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2019-03-14. Estimated completion is 2023-02-09.
What interventions are being tested in trial NCT02085421?
The interventions under investigation include: tDCS (DEVICE).
Who is sponsoring clinical trial NCT02085421?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.